http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103142617-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b26e17432236aa949f62b08733832285 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34 |
| filingDate | 2013-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_956cbf1af55f8e6237a5c6b6764376ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5f5c7b6d6b44c5b19dd0849a03bf42a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_413e724675443db678884e1d16234836 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fcc7e8e1a255cecdff77a07fa47fd27 |
| publicationDate | 2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103142617-B |
| titleOfInvention | Cefuroxime lysine medicinal composition |
| abstract | The invention relates to cefuroxime lysine, and particularly relates to a cefuroxime lysine medicinal composition. The cefuroxime lysine medicinal composition comprises cefuroxime lysine and sodium chloride serving as active ingredients in a weight ratio of 10: (0.1-2), and at least one of mannitol, sorbitol, sodium bisulfite and sodium metabisulfite can be added to the active ingredients. The cefuroxime lysine medicinal composition has the advantages of low impurity content, good stability and high flowability and is very suitable for clinical application. |
| priorityDate | 2013-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.